regulatory
confidence high
sentiment negative
materiality 0.60
GridAI Technologies Corp. (GRDX): Nasdaq/NYSE listing notice — Entero Therapeutics receives Nasdaq notice for missing 2024 annual meeting
GridAI Technologies Corp.
- Notice received Jan 7, 2025 for non-compliance with Nasdaq Listing Rule 5620(a) due to no 2024 annual meeting.
- Company has until Feb 21, 2025 to submit a compliance plan; extension possible to June 30, 2025.
- Intends to hold annual meeting as soon as practicable and will file a proxy statement.
- Notice has no immediate effect on listing or trading of common stock (ENTO).
- Failure to regain compliance may lead to delisting; company can appeal to Nasdaq hearings panel.